Combination Bacillus Calmette–Guérin and indoleamine 2,3‐dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer
Saved in:
Published in | BJU international Vol. 126; no. 5; pp. 554 - 556 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Author | Tang, Lloyd Wei Tat Tham, Sin Mun Chiong, Edmund Kioh, Dorinda Yan Qin Mahendran, Ratha Esuvaranathan, Kesavan Lee, Sze Han Thamboo, Thomas Paulraj Chan, Eric Chun Yong |
---|---|
Author_xml | – sequence: 1 givenname: Sze Han surname: Lee fullname: Lee, Sze Han organization: National University of Singapore – sequence: 2 givenname: Ratha surname: Mahendran fullname: Mahendran, Ratha organization: National University of Singapore – sequence: 3 givenname: Sin Mun surname: Tham fullname: Tham, Sin Mun organization: National University Hospital – sequence: 4 givenname: Thomas Paulraj surname: Thamboo fullname: Thamboo, Thomas Paulraj organization: National University Hospital – sequence: 5 givenname: Dorinda Yan Qin surname: Kioh fullname: Kioh, Dorinda Yan Qin organization: National University of Singapore – sequence: 6 givenname: Lloyd Wei Tat surname: Tang fullname: Tang, Lloyd Wei Tat organization: National University of Singapore – sequence: 7 givenname: Edmund surname: Chiong fullname: Chiong, Edmund organization: National University Hospital – sequence: 8 givenname: Kesavan surname: Esuvaranathan fullname: Esuvaranathan, Kesavan organization: National University Hospital – sequence: 9 givenname: Eric Chun Yong orcidid: 0000-0001-6107-9072 surname: Chan fullname: Chan, Eric Chun Yong email: eric.chan@nus.edu.sg organization: National University of Singapore |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32770708$$D View this record in MEDLINE/PubMed |
BookMark | eNp10c1qFTEYBuAgFfujC2-gBLpR6Gm_JPOTWdpDW5WCGwvuhmTmiyeHTHKazKBn196B0KvwOryTXklTT-uiYCAkJA8vIe8u2fLBIyFvGRyxPI71cjpiJQf2guywoipmBYNvW097aKptspvSEiAfVOUrsi14XUMNcofczMOgrVejDZ6eqM46NyU6V27AccS769vz6c_vaD1VvqfW98GhGqxHyg_F3fWv3oaf6-_oVULK8v3CajuGSMcFRrVa02DoMMUHH-K4CGNY2Y5qp_oeI-2U7zC-Ji-NcgnfPK575PLs9Ov84-ziy_mn-YeLWSdKwWbGgGaylqYS0EOjdVODYY0qea2lLExXllIZI7luCmFKjQCyQKkBCgGIXOyRd5vcVQxXE6axHWzq0DnlMUyp5YVgMn8Kh0wPntFlmKLPr8uqrGrG88zq_UZ1MaQU0bSraAcV1y2D9qGXNvfS_u0l2_3HxEkP2P-TT0VkcLwBP6zD9f-T2pPPl5vIexagm94 |
CitedBy_id | crossref_primary_10_1016_j_biopha_2020_111077 |
Cites_doi | 10.1038/s41598-019-43641-5 10.1016/j.tips.2017.11.007 10.1200/JCO.2019.37.7_suppl.TPS493 10.1016/j.eururo.2006.01.017 10.1016/S1043-4666(02)00490-8 |
ContentType | Journal Article |
Copyright | 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd BJUI © 2020 BJU International |
Copyright_xml | – notice: 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd – notice: BJUI © 2020 BJU International |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7X8 |
DOI | 10.1111/bju.15201 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1464-410X |
EndPage | 556 |
ExternalDocumentID | 10_1111_bju_15201 32770708 BJU15201 |
Genre | letter Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National University Health System (NUHS) Innovation Grant funderid: NUHSRO/2018/041/Innov/03 – fundername: National University Health System (NUHS) Innovation Grant grantid: NUHSRO/2018/041/Innov/03 |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HF~ HGLYW HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7QP 7X8 |
ID | FETCH-LOGICAL-c3531-ff0b1878f630d09bb970f19a527b884fc558aff82b943f5be0084e8b00430ee23 |
IEDL.DBID | DR2 |
ISSN | 1464-4096 |
IngestDate | Wed Dec 04 12:05:59 EST 2024 Thu Oct 10 15:28:05 EDT 2024 Fri Dec 06 01:05:45 EST 2024 Sat Sep 28 08:39:42 EDT 2024 Sat Aug 24 01:03:51 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3531-ff0b1878f630d09bb970f19a527b884fc558aff82b943f5be0084e8b00430ee23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6107-9072 |
PMID | 32770708 |
PQID | 2456712671 |
PQPubID | 1026371 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_2431807020 proquest_journals_2456712671 crossref_primary_10_1111_bju_15201 pubmed_primary_32770708 wiley_primary_10_1111_bju_15201_BJU15201 |
PublicationCentury | 2000 |
PublicationDate | November 2020 2020-11-00 20201101 |
PublicationDateYYYYMMDD | 2020-11-01 |
PublicationDate_xml | – month: 11 year: 2020 text: November 2020 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Edgecliff |
PublicationTitle | BJU international |
PublicationTitleAlternate | BJU Int |
PublicationYear | 2020 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2017; 119 2018; 39 2019; 9 2015; 4 2006; 49 2003; 21 2019; 37 Von Rundstedt FC (e_1_2_4_6_1) 2015; 4 Tham SM (e_1_2_4_5_1) 2017; 119 e_1_2_4_3_1 e_1_2_4_2_1 e_1_2_4_4_1 e_1_2_4_7_1 e_1_2_4_8_1 |
References_xml | – volume: 49 start-page: 790 year: 2006 end-page: 7 article-title: Management of BCG failures in superficial bladder cancer: a review publication-title: Eur Urol – volume: 37 start-page: TPS493 issue: Suppl year: 2019 article-title: A phase II, randomized study of nivolumab (nivo) or nivo plus BMS‐986205 with or without intravesical Bacillus Calmette‐Guerin (BCG) in BCG‐unresponsive, high‐risk, non‐muscle invasive bladder cancer (NMIBC): CheckMate 9UT publication-title: J Clin Oncol – volume: 9 start-page: 7425 year: 2019 article-title: Enhanced metastatic potential in the MB49 urothelial carcinoma model publication-title: Sci Rep – volume: 21 start-page: 17 year: 2003 end-page: 26 article-title: Role of Th1 and Th2 cytokines in BCG‐induced IFN‐γ production: cytokine promotion and simulation of BCG effect publication-title: Cytokine – volume: 39 start-page: 307 year: 2018 end-page: 25 article-title: Targeting the IDO1/TDO2‐KYN‐AhR pathway for cancer immunotherapy ‐ challenges and opportunities publication-title: Trends Pharmacol Sci – volume: 119 year: 2017 article-title: A murine orthotopic bladder tumor model and tumor detection system publication-title: J Vis Exp – volume: 4 start-page: 244 year: 2015 end-page: 53 article-title: Bacille‐Calmette‐Guerin non‐responders: how to manage publication-title: Transl Androl Urol – ident: e_1_2_4_7_1 doi: 10.1038/s41598-019-43641-5 – ident: e_1_2_4_4_1 doi: 10.1016/j.tips.2017.11.007 – ident: e_1_2_4_8_1 doi: 10.1200/JCO.2019.37.7_suppl.TPS493 – volume: 4 start-page: 244 year: 2015 ident: e_1_2_4_6_1 article-title: Bacille‐Calmette‐Guerin non‐responders: how to manage publication-title: Transl Androl Urol contributor: fullname: Von Rundstedt FC – volume: 119 start-page: e55078 year: 2017 ident: e_1_2_4_5_1 article-title: A murine orthotopic bladder tumor model and tumor detection system publication-title: J Vis Exp contributor: fullname: Tham SM – ident: e_1_2_4_2_1 doi: 10.1016/j.eururo.2006.01.017 – ident: e_1_2_4_3_1 doi: 10.1016/S1043-4666(02)00490-8 |
SSID | ssj0014665 |
Score | 2.3803902 |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 554 |
SubjectTerms | Acetamides - pharmacology Acetamides - therapeutic use Animals Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use BCG Vaccine - pharmacology BCG Vaccine - therapeutic use Bladder cancer Dioxygenase Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors Kynurenine - blood Mice Neoplasms, Experimental - chemistry Neoplasms, Experimental - drug therapy Quinolines - pharmacology Quinolines - therapeutic use Urinary Bladder - chemistry Urinary Bladder - drug effects Urinary Bladder Neoplasms - chemistry Urinary Bladder Neoplasms - drug therapy |
Title | Combination Bacillus Calmette–Guérin and indoleamine 2,3‐dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbju.15201 https://www.ncbi.nlm.nih.gov/pubmed/32770708 https://www.proquest.com/docview/2456712671 https://search.proquest.com/docview/2431807020 |
Volume | 126 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB5CCiWX_qd1mwal9NBDHGzZXsv0lE26DYH0ULqQQ8BI9oi43djBax_aU_oGhT5Fn6NvkifpSP6haQiEHowNkpCs-dE3kmYG4HUSBlqIbOISlA_dUGvhygBDN9I595XwJ2i3Bo4-TA7m4eFxdLwCbwdfmC4-xLjhZiTD6msj4FIt_xJy9bk1yXus75YfxOY63_7HMXQUKQCbRpLeNATC6X1UIXOLZ2x5dS26BjCv4lW74Mzuw8kw1O6eyZedtlE72bd_ojj-5788gHs9EGW7Hec8hBUsH8Hdo_6o_TF8J01BVrMlHJvKrFgs2iXbM-lWmgYvL36-b3__qouSyTJnZNhXC5Rn1JLx7eDy4kde0LCJOWmRZD6VnxaKdEfNOn-vr6zS7Mxs9CMzB0dVU50XGVMLowdrlhlWrJ_AfPbu096B2-drcLOARNnV2lO-iIWeBF7uJUolsaf9REY8VkKEOosiIYkbuDIcEik0wfxRKBt3DJEH67BaViU-A6Yx4UIqhYgEKTFXSlMXGBE80mEsuQOvBsql511YjnQwZ2gyUzuZDmwMNE17yVym5qA39jk9DmyNxSRT5qBElli1pg5pOtKF3HPgaccLYy8Bj2MqEg68sRS9uft0eji3H89vX_UFrHFj0Ftnxw1YbeoWXxLqadQm3Nmd7k9nm5bN_wD57AHh |
link.rule.ids | 314,780,784,1375,27924,27925,46294,46718 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1LbtUwcFS1ErApfxooYBALFqRKnOTFkdjQQnmUvi5Qn9QNiuxkLNK-JlWaLMqq3ACJU3AObtKTMHY-oiAkxCJKJNuy4_l4Pp4ZgGdJGGghsolLonzohloLVwYYupHOua-EP0FrGpjtTabzcOcgOliCl0MsTJcfYjS4Gcqw_NoQuDFI_0Ll6rA11XtM8NYKkbtvLnS9_jAmjyIWYAtJ0psWQZJ6n1fI3OMZh14-jf4QMS9LrPbI2b4OH4fFdjdNjjbaRm1kn3_L4_i_f3MDVntZlL3qkOcmLGF5C67Mem_7bfhCzIIUZws7timzYrFoT9mWqbjSNHhx_u1t--N7XZRMljkj3b5aoDymkYy_CC7Ov-YFrZvwk85J5lP7p0IR-6hZF_J1xirNjo2tH5nxHVVNdVJkTC0MK6xZZrCxvgPz7Tf7W1O3L9ngZgFRs6u1p3wRCz0JvNxLlEpiT_uJjHishAh1FkVCEkJwZZAkUmjy-aNQNvUYIg_uwnJZlbgGTGPChVQKEUmqxFwpTVNgRBKSDmPJHXg6gC496TJzpINGQ5uZ2s10YH0AatoT52lqfL2xz-lx4MnYTGRlfCWyxKo1fYjZETvkngP3OmQYZwl4HFOTcOC5Benfp083d-b24_6_d30MV6f7s910993e-wdwjRv93sY-rsNyU7f4kISgRj2yuP4T8j8EkA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwEB1VRarY8H6kFDCIBQtSJc7LESvacimFVghxpS6QIjsZi9Db5CpNFrAqf4DEV_Ad_Em_hLHzEAUhIRZRItmWHc_DZzyeMcCjNAy0EHnsEpQP3VBr4coAQzfSBfeV8GO0WwP7B_HuPNw7jA5X4OkYC9Pnh5g23IxkWH1tBHxZ6F-EXH3szOU9JnbrQhjz1CTO33k75Y4iDWDvkaQ3jYGA-pBWyBzjmZqeX4z-QJjnAatdcWaX4f041v6gydFm16rN_PNvaRz_82euwKUBibJnPetchRWsrsHa_uBrvw5fSFWQ2Wwpx7ZkXi4W3QnbNvettC2enX570f343pQVk1XByLKvFyiPqSXjT4Kz069FScMm7qRVkvlU_qFUpDwa1gd8fWK1Zsdmpx-Z8RzVbb0sc6YWRhE2LDe82NyA-ez5u-1dd7iwwc0DkmVXa0_5IhE6DrzCS5VKE0_7qYx4ooQIdR5FQhI7cGVYJFJosvmjUDbxGCIPbsJqVVd4G5jGlAupFCISpsRCKU1dYET4SIeJ5A48HCmXLfu8HNloz9BkZnYyHdgYaZoNonmSGU9v4nN6HHgwFZNQGU-JrLDuTB1SdaQMuefArZ4Xpl4CniRUJBx4bCn69-6zrb25_Vj_96r3Ye3Nzix7_fLg1R24yI1xbwMfN2C1bTq8SwioVfcsp_8E72gDPw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combination+Bacillus+Calmette%E2%80%93Gu%C3%A9rin+and+indoleamine+2%2C3%E2%80%90dioxygenase+1+inhibitor+therapy+of+murine+orthotopic+bladder+cancer&rft.jtitle=BJU+international&rft.au=Lee%2C+Sze+Han&rft.au=Mahendran%2C+Ratha&rft.au=Tham%2C+Sin+Mun&rft.au=Thamboo%2C+Thomas+Paulraj&rft.date=2020-11-01&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=126&rft.issue=5&rft.spage=554&rft.epage=556&rft_id=info:doi/10.1111%2Fbju.15201&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_bju_15201 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon |